.@newlimit is building medicines that target aging itself—not just individual diseases. Their approach is elegant and deeply technical: run the largest epigenetic reprogramming experiments and use the data to train frontier AI models. Proud to lead their Series B and back @brian_armstrong, @byersblake, @jacobkimmel, and Cathy O’Hare on this mission. Interested in joining their talented team on the journey? They’re hiring: